Vimian Group AB (publ) (VIMGF)
OTCMKTS
· Delayed Price · Currency is USD
3.990
0.00 (0.00%)
At close: Jun 23, 2025
Vimian Group AB Revenue
Vimian Group AB had revenue of 107.50M EUR in the quarter ending March 31, 2025, with 17.74% growth. This brings the company's revenue in the last twelve months to 391.00M, up 16.75% year-over-year. In the year 2024, Vimian Group AB had annual revenue of 374.80M with 12.99% growth.
Revenue (ttm)
391.00M EUR
Revenue Growth
+16.75%
P/S Ratio
5.21
Revenue / Employee
325.83K EUR
Employees
1,200
Market Cap
2.20B USD
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |